Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA approves Lynparza with bevacizumab for HRD-positive advanced ovarian cancer

May 11, 2020

Oncoinvent recruits for phase I study of Radspherin

May 11, 2020

FDA approves Retevmo for advanced RET-driven lung and thyroid cancers

May 11, 2020

SCN10A gene loss-of-function variant linked to neuropathy

May 11, 2020

FDA and China NMPA clear IND for Mabspace's humanized Claudin18.2 monoclonal antibody

May 11, 2020

ZFYVE21 is a potential therapeutic target in cardiac allograft vasculopathy

May 11, 2020

Seattle Genetics initiates phase I study of SGN-TGT in advanced solid tumors and lymphomas

May 11, 2020

Roche describes new hepatitis B virus cccDNA formation inhibitors

May 11, 2020

Shanghai Yichen Biomed patents EGFR-PD-1 bispecific antibodies

May 11, 2020

Shanghai GeneChem synthesizes anti-CLDN128.2 antibodies

May 11, 2020

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...